Assistant Professor Discusses Treatment for Lung Cancer

Lara Kujtan, M.D., of the UMKC School of Medicine, talked about frontline therapy for patients
The topic centered on EGFR-positive non–small cell lung cancer (NSCLC). Learn more on OncLive.

Learn more about School of Medicine

Published: Feb 6, 2019

Top Stories